Trials / Completed
CompletedNCT00720278
A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 and MP03-33 Compared to Placebo in Patients With Seasonal Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 526 (actual)
- Sponsor
- Meda Pharmaceuticals · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to determine if two allergy medications are more effective than placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.15% azelastine hydrochloride 1644 mcg daily | 0.15% azelastine hydrochloride 1644 mcg daily |
| DRUG | 0.1% azelastine hydrochloride 1096 mcg daily | 0.1% azelastine hydrochloride 1096 mcg daily |
| DRUG | Placebo | 0 mcg Placebo daily |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2007-10-01
- Completion
- 2007-11-01
- First posted
- 2008-07-22
- Last updated
- 2010-03-02
- Results posted
- 2009-10-27
Locations
29 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00720278. Inclusion in this directory is not an endorsement.